After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
DVAX belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $13.99 and fluctuated between $14.09 as its day high and $13.80 as its day low. The current market capitalization of Dynavax Technologies Corp. is $1.81B. A total of 2.46 million shares were traded on the day, compared to an average of 1.68M shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, DVAX has seen 2 BUY and 2 SELL insider trades, representing the acquisition of 40,000 and the disposition of 40,000 shares. Over the last 12 months, there were 38 BUYs and 35 SELLs from insiders. Insiders purchased 379,011 shares during that period but sold 3,290,474.
In the most recent transaction, Janssen Robert sold 1,500 shares of DVAX for 15.00 per share on Jan 04. After the transaction, the SVP and CMO now owns 49,925 company shares. In a previous transaction on Jan 02, Novack David F sold 9,000 shares at 14.45 per share. DVAX shares that President & COO owns now total 3,187.
Among the insiders who sold shares, Novack David F disposed of 20,000 shares on Dec 01 at a per-share price of $13.56. This resulted in the President & COO holding 3,187 shares of DVAX after the transaction. In another insider transaction, Novack David F sold 20,000 shares at $15.00 per share on Nov 03. Company shares held by the President & COO now total 3,187.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for DVAX in the last 3 months, the mean price target is $25.40 with high estimates of $29.00 and low estimates of $21.00. In terms of 52-week highs and lows, DVAX has a high of $15.15 and a low of $9.42.
As of this writing, DVAX has an earnings estimate of -$0.01 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0.01 per share and a lower estimate of -$0.03. The company reported an EPS of $0.03 in the last quarter, which was 133.30% higher than expectations of -$0.09.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. DVAX’s latest balance sheet shows that the firm has $545.95M in Cash & Short Term Investments as of fiscal 2021. There were $257.38M in debt and $556.40M in liabilities at the time. Its Book Value Per Share was $4.68, while its Total Shareholder’s Equity was $222.37M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DVAX is Buy with a score of 5.00.
